BiopharmaTrend.com

A fresh viewpoint on drug discovery, pharma, and biotech

Subscribe | Become an author | Author LogIn

White Papers And Industry Reports

Trends, opportunities and the future of drug discovery

Direct-to-Consumer Genetic Testing Market to hit USD 2.5 Bn by 2024

   by Global Market Insights    79
Direct-to-Consumer Genetic Testing Market to hit USD 2.5 Bn by 2024

Direct-to-Consumer (DTC) Genetic Testing Market size is set to exceed USD 2.5 billion by 2024; according to a new research report by Global Market Insights.

Growing incidences of genetic and rare disorders worldwide coupled with wide applications of direct-to-consumer genetic testing in early detection and prevention of oncology as well as other genetic diseases will drive the DTC genetic testing market growth in the coming years. Rising awareness among patients pertaining to early disease diagnosis will result in timely treatment and reduced mortality rate. Additionally, technological innovations in direct-to-consumer genetic testing to offer enhanced efficiency, high sensitivity and accuracy will serve to be a significant impact rendering factor. Moreover, increasing adoption of carrier testing at a very early stage of pregnancy will further augment the business growth during forecast period.

Navigating the Challenges of Pharmaceutical Marketing

   by Ben Ramsbottom    105
Navigating the Challenges of Pharmaceutical Marketing

According to a research report by The Business Research Company, the global pharmaceuticals market was worth $934.8 billion in 2017. This will continue to rise, reaching an incredible $1,170 billion by 2021.

Those who work within the field of pharmaceuticals are well aware of the fragmented and fluctuating nature of the industry. This growing industry is trying to adapt to an ever-changing world in terms of communication, but it is experiencing some roadblocks along the way. We look at some of the most notable challenges facing pharmaceutical marketing today.

2018: AI Is Surging In Drug Discovery Market

   by Andrii Buvailo    8873
2018: AI Is Surging In Drug Discovery Market

Updated: 10.01.2019. Newly added content is marked in the text with "Update" sign.

The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate of pharmaceutical research programs has inspired a surge of activity in this area over the last several years. In 2018, things are getting even “hotter” with the increase in the amount of partnerships, investments and other important events, summarized and grouped below into “mini-trends”.

Microsurgery Robot Market to Amass Considerable Returns from Hospital & Clinical Pursuits, Global Industry to be Characterized by Cutting-edge Technological Advancements

   by Global Market Insights    323
Microsurgery Robot Market to Amass Considerable Returns from Hospital & Clinical Pursuits, Global Industry to be Characterized by Cutting-edge Technological Advancements

The deployment of robotics in healthcare to perform complex surgeries with more precision and accuracy has indeed propelled microsurgery robot market trends. Over the last few years robotics is being incorporated prominently in gastrointestinal, gynecological, and urological surgeries, owing to the growing awareness among the healthcare service providers and patients about minimally invasive treatments. Many patients with terminal disorders such as endometrial cancer have also found to be inclined toward robotic techniques. The increasing use of such innovative and minimally invasive medical treatment facilities is slated to fuel microsurgery robot industry size.